EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Signal Transducer and Activator of Transcription 3 (STAT3) Variant p.K709N Causes Hyper‐IgE Syndrome Likely by Impaired STAT3‐Dimer Formation

Beate Hagl iD, Benedikt D Spielberger, Betina Neumann, Simon J Pelham, Dharmendra Pandey, Andreas Schlundt, Camille Barro, Anica Lechner, Christine Wolf, Elissa K Deenick, Michael Sattler, Stuart G Tangye und 2 weitere

European Journal of Immunology · 2025

DOI: 10.1002/eji.70015 ↗

Kurz gefasst

Fallbericht in der Zeitschrift European Journal of Immunology, 2025. Verfasst von Beate Hagl und 13 weiteren Autor:innen. Beteiligte Einrichtung: Translational Immunology, Faculty of Medicine, University of Augsburg, Augsburg, Germany. Hauptthemen laut MEDLINE: Job Syndrome, STAT3 Transcription Factor. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Helmholtz Association, Helmholtz-Future topic "Immunology and Inflammation".

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

STAT3‐hyper‐IgE syndrome (STAT3‐HIES) is an inborn error of immunity caused by heterozygous dominant‐negative mutations in the signal transducer and activator of transcription 3 (STAT3). In this study, we evaluate the functional relevance of a previously undescribed heterozygous STAT3 variant in a patient with clinical findings of STAT3‐HIES. Flow cytometry, quantitative real‐time PCR, pull‐down assays, native PAGE, DNA‐binding ELISA, and 3D‐structural data analysis were performed. Genetic analysis identified the heterozygous STAT3 variant NM_139276.2:c.2127G>C (NP_644805.1:p.(K709N); short: p.K709N) in a patient with a clinical and laboratory phenotype characteristic of STAT3‐HIES, including early onset severe eczema, chronic lung disease, eosinophilia, and elevated serum IgE levels. While STAT3 p.K709N did not significantly affect STAT3 phosphorylation, STAT3 target gene expression was impaired in patient cells. Expression of STAT3 p.K709N and wild‐type STAT3 in STAT3‐deficient cells indicated a dominant‐negative effect by the mutation. Analysis of 3D‐structural data and modeling suggested a central role of the affected amino acid K709 in stabilizing a C‐terminal loop in STAT3 essential for dimer formation. Consequently, p.K709N resulted in diminished STAT3 dimerization and reduced DNA binding in patient cells. Functional analyses verified STAT3 p.K709N to cause STAT3‐HIES and suggest that STAT3 p.K709N impairs STAT3 dimer formation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Job SyndromeSTAT3 Transcription FactorFemaleHumansImmunoglobulin EMutationPhosphorylationProtein MultimerizationAdult

Stichwörter der Autor:innen

HIESHyper‐IgE syndromeSTAT3dimerizationvariant classification

Substanzen

Immunoglobulin ESTAT3 protein, humanSTAT3 Transcription Factor

Autor:innen und Institutionen

  • Translational Immunology, Faculty of Medicine, University of Augsburg, Augsburg, Germany.
  • Translational Immunology in Environmental Medicine, School of Medicine and Health, Technical University of Munich, Munich, Germany.
  • Institute of Lung Health and Immunity (LHI), Helmholtz Munich, Comprehensive Pneumology Center (CPC-M), German Center of Lung Research (DZL), Munich, Germany.
  • Department of Pediatrics, TUM University Hospital, School of Medicine and Health, Technical University of Munich, Munich, Germany.
  • Department of Pediatrics, Dr. Von Hauner Children's Hospital, LMU University Hospital, LMU Munich, Munich, Germany.
  • Garvan Institute of Medical Research, Sydney, Australia.

ORCID-Profile: Beate Hagl, Ellen D Renner

Förderung

  • Deutsche Forschungsgemeinschaft
  • Helmholtz Association
  • Helmholtz-Future topic "Immunology and Inflammation"
  • Fritz Bender Stiftung
  • Job Research Foundation
  • Wilhelm Sander-Stiftung
  • National Health and Medical Research Council
  • European Union

Zitieren

APA

Hagl, B., Spielberger, B. D., Neumann, B., Pelham, S. J., Pandey, D., Schlundt, A., Barro, C., Lechner, A., Wolf, C., Deenick, E. K., Sattler, M., Tangye, S. G., Rothenfusser, S., & Renner, E. D. (2025). Signal Transducer and Activator of Transcription 3 (STAT3) Variant p.K709N Causes Hyper‐IgE Syndrome Likely by Impaired STAT3‐Dimer Formation. European Journal of Immunology. https://doi.org/10.1002/eji.70015

Vancouver

Hagl B, Spielberger BD, Neumann B, Pelham SJ, Pandey D, Schlundt A, et al. Signal Transducer and Activator of Transcription 3 (STAT3) Variant p.K709N Causes Hyper‐IgE Syndrome Likely by Impaired STAT3‐Dimer Formation. European Journal of Immunology. 2025. doi:10.1002/eji.70015

BibTeX
@article{Hagl2025,
  author = {Hagl, Beate and Spielberger, Benedikt D and Neumann, Betina and Pelham, Simon J and Pandey, Dharmendra and Schlundt, Andreas and Barro, Camille and Lechner, Anica and Wolf, Christine and Deenick, Elissa K and Sattler, Michael and Tangye, Stuart G and Rothenfusser, Simon and Renner, Ellen D},
  title = {Signal Transducer and Activator of Transcription 3 (STAT3) Variant p.K709N Causes Hyper‐IgE Syndrome Likely by Impaired STAT3‐Dimer Formation},
  journal = {European Journal of Immunology},
  year = {2025},
  doi = {10.1002/eji.70015}
}
Kostenlos starten →